CrestecBio
Latest round
- Seed
Last raised
- Jun 2026
Total raised
- $1.6M
Investors
- 5
About CrestecBio
Founded in 2021 and based in Tsukuba, Japan, CrestecBio Inc. operates as a company that develops polymer pharmaceuticals for neuroprotection and organ protection, with CTB211 as its lead program for ischemic stroke. In June 2026, CrestecBio Inc. CrestecBio Inc. focuses on developing innovative polymer pharmaceuticals aimed at protecting the brain and organs. Their core product, CTB211, is a polymer micelle formulation that incorporates the nitroxyl radical TEMPO, enhancing its biological half-life from 15 seconds to 60 minutes. This product is designed to effectively eliminate reactive oxygen species in various central nervous system cells, providing neuroprotective effects, with applications in treating ischemic strokes and other conditions. The company targets markets in Japan and the United States, with potential extensions into Europe and Asia, catering to healthcare providers, research institutions, and pharmaceutical partners. CrestecBio Inc. generates revenue through partnerships with healthcare institutions and pharmaceutical companies interested in CTB211. The company engages in B2B transactions under contractual agreements, which may include volume pricing for large-scale purchases or research collaborations. Revenue structures may also involve licensing agreements, where partners pay for rights to use proprietary technology in clinical settings, or direct sales to hospitals and research facilities. As CTB211 proceeds through clinical trials, strategic alliances are expected to bolster revenue as the company delivers its therapeutic solutions globally. As of June 2026, the company plans to initiate clinical trials for CTB211, expand its pipeline, strengthen development partnerships, and advance polymer drug applications across oxidative stress related diseases.
Who invested in CrestecBio
5 investors across 2 rounds
See all investors in CrestecBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CrestecBio
Who invested in CrestecBio?
CrestecBio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CrestecBio raised?
CrestecBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CrestecBio last raise money?
CrestecBio's most recent round on record is a Seed, in Jun 2026.
What does CrestecBio do?
Founded in 2021 and based in Tsukuba, Japan, CrestecBio Inc.
Where is CrestecBio headquartered?
CrestecBio is headquartered in Tsukuba, Japan.
Which VCs invest in companies like CrestecBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at CrestecBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CrestecBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.